drugset / Trial / NCT03245970

Impedance Cardiography to Decrease the Risk of Preeclampsia

NCT03245970

RandomizedParallel-groupOpen-labelPrevention

Summary

To determine if the use of impedance cardiography can identify appropriate medications for use in treating chronic hypertensive patients to decrease the risk of preeclampsia.

Timeline

Start
2017-04-24
Primary completion
2020-02-29
Completion
2020-02-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atenolol Other / unclassified 25 mg
Comparator Labetalol Small molecule 200 mg Oral
Comparator Nifedipine Other / unclassified 60 mg Oral

Indications